Gene · 274
Papers2,900
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,900
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer's Disease. | Biomedicines | 2023 | 38137453 | PubTator, text mining | PubMed |
| Membrane Proteins and Membrane Curvature: Mutual Interactions and a Perspective on Disease Treatments. | Biomolecules | 2023 | 38136643 | PubTator, text mining | PubMed |
| The Impact of Apolipoprotein E (APOE) Epigenetics on Aging and Sporadic Alzheimer's Disease. | Biology (Basel) | 2023 | 38132357 | PubTator, text mining | PubMed |
| Nanopore Single-molecule Analysis of Biomarkers: Providing Possible Clues to Disease Diagnosis. | Trends Analyt Chem | 2023 | 38106545 | PubTator, text mining | PubMed |
| Genome-wide association study in Alzheimer's disease: a bibliometric and visualization analysis. | Front Aging Neurosci | 2023 | 38094504 | PubTator, text mining | PubMed |
| Identification of candidate DNA methylation biomarkers related to Alzheimer's disease risk by integrating genome and blood methylome data. | Transl Psychiatry | 2023 | 38092781 | PubTator, text mining | PubMed |
| SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts. | Stem Cell Res Ther | 2023 | 38087340 | PubTator, text mining | PubMed |
| Characteristics of ABCC4 and ABCG2 High Expression Subpopulations in CRC-A New Opportunity to Predict Therapy Response. | Cancers (Basel) | 2023 | 38067326 | PubTator, text mining | PubMed |
| Spatial Transcriptomics Reveals Signatures of Histopathological Changes in Muscular Sarcoidosis. | Cells | 2023 | 38067175 | PubTator, text mining | PubMed |
| Prostate cancer genetic risk and associated aggressive disease in men of African ancestry. | Nat Commun | 2023 | 38052806 | PubTator, text mining | PubMed |
| Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease. | Nat Commun | 2023 | 38036535 | PubTator, text mining | PubMed |
| RBFOX2 regulated EYA3 isoforms partner with SIX4 or ZBTB1 to control transcription during myogenesis. | iScience | 2023 | 38026174 | PubTator, text mining | PubMed |
| CircDDX17 inhibits invasive progression of pituitary adenomas by sponging miR-1279 and regulating CADM2 expression. | Front Oncol | 2023 | 38023219 | PubTator, text mining | PubMed |
| Computational analysis of five neurodegenerative diseases reveals shared and specific genetic loci. | Comput Struct Biotechnol J | 2023 | 38022694 | PubTator, text mining | PubMed |
| Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies. | Int J Mol Sci | 2023 | 38003477 | PubTator, text mining | PubMed |
| Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms. | Genes (Basel) | 2023 | 38002991 | PubTator, text mining | PubMed |
| Protein Biomarkers Shared by Multiple Neurodegenerative Diseases Are Calmodulin-Binding Proteins Offering Novel and Potentially Universal Therapeutic Targets. | J Clin Med | 2023 | 38002659 | PubTator, text mining | PubMed |
| Alzheimer's genes in microglia: a risk worth investigating. | Mol Neurodegener | 2023 | 37986179 | PubTator, text mining | PubMed |
| Clinical biomarkers for Lewy body diseases. | Cell Biosci | 2023 | 37964309 | PubTator, text mining | PubMed |
| Genomic and Reverse Translational Analysis Discloses a Role for Small GTPase RhoA Signaling in the Pathogenesis of Schizophrenia: Rho-Kinase as a Novel Drug Target. | Int J Mol Sci | 2023 | 37958606 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/274/papers?page=11